Filtered By:
Specialty: Universities & Medical Training
Condition: Thrombosis
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 257 results found since Jan 2013.
Independent risk factors of atrial thrombosis in patients with nonvalvular atrial fibrillation and low CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc scores
CONCLUSIONS: LAD enlargement, HCM, and an elevated CRP level are independent risk factors for atrial thrombosis in NVAF patients with low CHA2DS2-VASc scores.Active anticoagulation therapy should be administered for these patients once these risk factors are detected to prevent the occurrence of stroke.PMID:34549717 | DOI:10.12122/j.issn.1673-4254.2021.08.17
Source: Journal of Southern Medical University - September 22, 2021 Category: Universities & Medical Training Authors: M Zhou J Chen H Wang S Xi T Gan L Zhao Source Type: research
Relation of apixaban bleeding rates to dose in patients with chronic kidney disease
The objective of this study was to evaluate the safety and efficacy of apixaban 5 mg twice daily vs 2.5 mg twice daily for nonvalvular atrial fibrillation or venous thromboembolism in patients with chronic kidney disease stage 4 and 5, including those on hemodialysis. Data were collected retrospectively on patients with advanced chronic kidney disease and nonvalvular atrial fibrillation and/or venous thromboembolism who received apixaban while hospitalized at our institution between January 2013 and August 2018. The 5 mg twice daily group included 22 patients, and the 2.5 mg twice daily group included 73 patients. There wa...
Source: Baylor University Medical Center Proceedings - August 30, 2021 Category: Universities & Medical Training Authors: Sarah Yun Regan Sevinsky Tasleem Spracklin Alexandra Tatara Andrew Zoltan Fenves Source Type: research
